ABCDEFGHIJKLMNOPQRSTUVWX
1
Drug or Drug ComboAnimal ModelTumor TypePrinicpal Investigator
Prinicpal Investigator's Email
Additional Contact Person
Additional Contact Person
2
CeritinibLarval ZebrafishNeuroblastoma, ALCLJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
3
CrizotinibLarval ZebrafishNeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
4
LorlatinibLarval ZebrafishNeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
5
TazemetostatLarval ZebrafishEwing Sarcoma, Melanotic SchwannomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
6
TemsirolimusLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
7
GemcitabineLarval ZebrafishEwing Sarcoma, Melanotic SchwannomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
8
GefitinibLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
9
VenetoclaxLarval ZebrafishNeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
10
AfuresertibLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
11
AlectinibLarval ZebrafishNeuroblastoma, ALCLJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
12
ImatinibLarval ZebrafishMelanotic Schwannoma, CMLJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
13
CisplatinLarval ZebrafishMelanotic Schwannoma, NeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
14
CetuximabLarval ZebrafishSpitzoid MelanomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
15
Cetuximab + IrinotecanLarval ZebrafishSpitzoid MelanomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
16
Irinotecan + TemozolomideLarval ZebrafishEwing Sarcoma, Melanotic SchwannomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
17
Irinotecan + Temozolomide + TemsirolimusLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
18
Gefitinib + GemcitabineLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
19
Gefintinb + TemozolomideLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
20
Cyclophospamide + TopotecanLarval ZebrafishNeuroblastoma, Melanotic SchwannomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
21
Cyclophospamide + Topotecan + CrizotinibLarval ZebrafishNeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
22
Cyclophospamide + Topotecan + CeritinibLarval ZebrafishNeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
23
Cyclophospamide + Topotecan + VenetoclaxLarval ZebrafishNeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
24
LenvatinibLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
25
TalazoparibLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
26
Talazoparib + IrinotecanLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
27
CabozantinibLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
28
Cyclophosphamide + Topotecan + CabozantinibLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
29
PaxalisibLarval ZebrafishEwing SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
30
Irinotecan + Temozolomide + alisertibLarval ZebrafishNeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
31
VolasertibLarval ZebrafishNeuroblastomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
32
PazopanibLarval ZebrafishUndifferentiated SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
33
Ifosfamide + EtoposideLarval ZebrafishUndifferentiated SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
34
Ifosfamide + Etoposide + LenvatinibLarval ZebrafishUndifferentiated SarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
35
Irinotecan + Temozolomide + TalazoparibLarval ZebrafishOsteosarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
36
PalbociclibLarval ZebrafishRhabdomyosarcoma fusion positiveJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
37
PonatinibLarval ZebrafishRhabdomyosarcoma fusion positiveJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
38
Palbociclib + TemsirolimusLarval ZebrafishRhabdomyosarcoma fusion positiveJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
39
Temsirolimus + Vinorelbine + CyclophosphamideLarval ZebrafishRhabdomyosarcoma fusion negativeJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
40
DasatinibLarval ZebrafishALLJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
41
Olaparib + TemsirolimusLarval ZebrafishEwing sarcomaJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
42
RegorafenibLarval ZebrafishGastrointestinal stromal tumourJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
43
RapamycinLarval ZebrafishLAMJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
44
DoxorubicinLarval ZebrafishT-ALLJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
45
DaunorubicinLarval ZebrafishAMLJason Bermanjberman@cheo.on.caNadine AzzamNAzzam@cheo.on.ca
46
VincristineMouse (Model M25FV24c)RMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
47
GSK2126458Mouse (Model M25FV24c)RMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
48
Vincristine + GSK2126458Mouse (Model M25FV24c)RMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
49
BEZ235Mouse (Model STS39 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
50
DoxorubicinMouse (Model STS39 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
51
Doxorubicin + BEZ235Mouse (Model STS39 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
52
BEZ235Mouse (Model SKLMS 1 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
53
DoxorubicinMouse (Model SKLMS 1 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
54
Doxorubicin + BEZ235Mouse (Model SKLMS 1 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
55
SimvastatinMouse (Model STS 148 xenograft)UPSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
56
DoxorubicinMouse (Model STS 148 xenograft)UPSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
57
Doxorubicin + SimvastatinMouse (Model STS 148 xenograft)UPSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
58
SimvastatinMouse (Model STS39 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
59
DoxorubicinMouse (Model STS39 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
60
Doxorubicin + SimvastatinMouse (Model STS39 xenograft)LMSRebecca Gladdygladdy@lunenfeld.caYael Babichevbabichev@lunenfeld.ca
61
OlaparibAdult ZebrafishMadline Hayesmadeline.hayes@sickkids.ca
62
TemozolomideAdult ZebrafishMadline Hayesmadeline.hayes@sickkids.ca
63
Olaparib & TemozolomideAdult ZebrafishMadline Hayesmadeline.hayes@sickkids.ca
64
Cyclophosphamide + DexamethasoneMouseGregor Reidgrogreid@mail.ubc.ca
65
OlaparibMouseGregor Reidgrogreid@mail.ubc.ca
66
DexamethasoneMouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
67
CyclophosphamideMouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
68
TemozolomideMouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
69
Proteasome Inhibitors (Bortezomib, Carfilzomib, Disulfiram/Cu+)MouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
70
PARP inhibitor (ABT888, Olaparib)MouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
71
HDAC InhibitorMouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
72
Kinase inhibitors (Ponatinib, AZD9291, AZD8186)MouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
73
Checkpoint Inhibitor (Ly2603618)MouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
74
NiclosamideMouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
75
MontelukastMouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
76
Bromodomain inhibitor (OTX015)MouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
77
ClioquinolMouseSubdermal, Leukemia, BrainDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
78
Aurora Kinase InhibitionDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
79
ZM 447439Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
80
VX-680Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
81
AZD1152Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
82
HER2/EGF-R InhibitionDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
83
LapatinibCell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
84
Canertinib (CI-1033)Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
85
BIBW 2992 (Tovok)Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
86
BMS-599626Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
87
Gefitinib (Iressa)Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
88
Erlotinib, HydrochlorideCell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
89
CUDC-101Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
90
WZ4002Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
91
DacomitinibCell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
92
mTOR InhibitionDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
93
Pp242Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
94
Rapamycin (Sirolimus)Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
95
AZD8055Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
96
INK128Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
97
OSI-027Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
98
PF-04691502Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
99
GDC-0980Cell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca
100
DeforolimusCell LinesDonna Sengersenger@ucalgary.caJennifer Chanjawchan@ucalgary.ca